Menu

Efficacy and Safety of Fenofibric Acid Co-Administered with Low- or Moderate-Dose Statin in Patients with Mixed Dyslipidemia and Type 2 Diabetes Mellitus: Results of a Pooled Subgroup Analysis from Three Randomized, Controlled, Double-Blind Trials

By Jones Peter H. in (2010)

Adis International

Abstract Access to resources Recommend Favorite

Predictors of Annual Pharmaceutical Costs in Australia for Community-Based Individuals with, or at Risk of, Cardiovascular Disease: Analysis of Australian Data from the REACH Registry

By Ademi Zanfina in (2010)

Adis International

Abstract Access to resources Recommend Favorite

Preservation of Bioavailability of Ingredients and Lack of Drug-Drug Interactions in a Novel Five-Ingredient Polypill (Polycap™): A Five-Arm Phase I Crossover Trial in Healthy Volunteers

By Patel Anil,Shah Tarang,Shah Gaurang,Jha Vijay,Ghosh Chinmoy,Desai Jagruti,Khamar Bakulesh,Chakraborty Bhaswat S. in (2010)

Adis International

Abstract Access to resources Recommend Favorite

Ethnicity/Race, Use of Pharmacotherapy, Scope of Physician-Ordered Cholesterol Screening, and Provision of Diet/Nutrition or Exercise Counseling during US Office-Based Visits by Patients with Hyperlipidemia

By Willson Megan N. in (2010)

Adis International

Abstract Access to resources Recommend Favorite

Extent of Control of Cardiovascular Risk Factors and Adherence to Recommended Therapies in US Multiethnic Adults with Coronary Heart Disease: From a 2005-2006 National Survey

By Vulic Dusko in (2010)

Adis International

Abstract Access to resources Recommend Favorite

Heterogeneity of Efficacy and Safety of Antiplatelet Therapy in Cardiovascular and Cerebrovascular Disease

By Gebel James M. in (2010)

Adis International

Abstract Access to resources Recommend Favorite

Low-Dose Aspirin Therapy for Cardiovascular Prevention: Quantification and Consequences of Poor Compliance or Discontinuation

By Herlitz Johan in (2010)

Adis International

Abstract Access to resources Recommend Favorite